Reitan Colleen F's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed May 12, 2025
- Accession no.
- 0001735276-25-000062
- Filed
- May 12, 2025
- Trade date
- Aug 29, 2024-May 8, 2025
- Filing delay
- 256 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market purchases total $10.4K. Open-market sales total $8.38K. It was filed 256 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reitan Colleen FCIK 0001740730 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Common Stock | PPurchaseAcquired | +32 | $286.00 | +$9,152 | 32 | Direct | |
| Oct 17, 2024 | Common Stock | PPurchaseAcquired | +4 | $302.67 | +$1,210.68 | 36 | Direct | |
| Apr 16, 2025 | Common Stock | SSaleDisposed | −36 | $232.86 | −$8,382.96 | 0 | Direct | |
| May 8, 2025 | Common Stock | AGrant or awardAcquired | +775 | $0.00 | $0 | 775 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | Common Stock | AGrant or awardAcquired | +1,558 | $0.00 | $0 | 1,558 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.